ARTICLE | Clinical News
Telapristone: Phase IIb started
January 26, 2015 8:00 AM UTC
Repros began a double-blind, placebo-controlled Phase IIb trial to evaluate 6 and 12 mg oral Proellex in 18-week courses for up to 2 courses in about 45 premenopausal woman. The courses will be separa...